JPRN-UMIN000010999
Completed
Phase 4
The efficacy of teneligliptin in diabetic patients on hemodialysis - The efficacy of teneligliptin in diabetic patients on hemodialysis
ConditionsType2 diabetic patients on hemodialysis
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Type2 diabetic patients on hemodialysis
- Sponsor
- Kawashima Hospital
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients having infectious diseases, thyroid disease, or malignant tumors. Patients being treated with steroids.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Efficacy of the medical compound of teneligliptin 20 mg and canagliflozin 100 mg with Free Style Libretype 2 diabetes mellitusJPRN-UMIN000029015TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology40
Completed
Not Applicable
Effects of one of antidiabetic agents, teneligliptin, on the vascular endothelium function of ACS patients with diabetesAcute Coronary Syndrome (ACS) and diabetesJPRN-UMIN000018936Saitama Medical Center, Jichi Medical University50
Completed
Not Applicable
Effects of teneligliptin on glycemic control and bone metabolic markers in diabetic patients undergoing hemodialysisdiabetic patients undergoing hemodialysisJPRN-UMIN000010780Diamond study group10
Completed
Phase 4
Clinical Study for the Effect of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-UMIN000014589TOPLEVEL study office936
Active, not recruiting
Phase 4
TOPLEVEL studyType 2 Diabetes MellitusJPRN-jRCTs051180136Kitakaze Masafumi936